INSIGHTS ON REGULATORY COMPLIANCE

• Enhancing Novel Developability Through Automated MS Analytics

  Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.

• Drug Substance For Early Clinical Phase Initiation

  Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.

• Shedding Light On Photo-Stability Forced Degradation

  Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

• Quality Over Checkbox Compliance: From QRM To Quality Maturity

  Quality maturity shifts asset management from compliance-focused to risk-based. Discover how performance-driven calibration and leading indicators create systems where quality outcomes become inevitable.

• Why You Need Spare Parts On-Hand

  3/10/2026

  Unexpected equipment failures can derail timelines and strain budgets. Proactively stocking the right spare parts helps labs minimize downtime, protect productivity, and maintain consistent performance.

• Scientific Data Is Not AI‑Ready By Default

  6/26/2026

  Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.

• Injection Site Reaction Screening Methodology

  6/6/2025

  Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

• Beyond Batch Release: Adjacent Use Cases For Agentic AI

  2/6/2026

  Agentic AI links yield optimization, maintenance, and supply chain planning into a unified system that strengthens manufacturing resilience. Explore how these capabilities drive smarter operations.

• Curia's Approach To Regulatory Compliance In Korea

  9/14/2026

  Navigating Asian pharma markets requires alignment with local regulations. Standardized documentation, facility registrations, and strong quality systems support compliance and reliable supply.